Form 8-K - Current report:
SEC Accession No. 0001193125-26-152868
Filing Date
2026-04-13
Accepted
2026-04-13 16:10:07
Documents
13
Period of Report
2026-04-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sana-20260410.htm   iXBRL 8-K 66894
2 EX-5.1 sana-ex5_1.htm EX-5.1 21793
3 EX-10.1 sana-ex10_1.htm EX-10.1 181087
4 GRAPHIC img155791035_0.gif GRAPHIC 42089
5 GRAPHIC img155791035_1.gif GRAPHIC 42089
  Complete submission text file 0001193125-26-152868.txt   561784

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sana-20260410.xsd EX-101.SCH 51351
16 EXTRACTED XBRL INSTANCE DOCUMENT sana-20260410_htm.xml XML 4890
Mailing Address 188 EAST BLAINE STREET, SUITE 350 SEATTLE WA
Business Address 188 EAST BLAINE STREET, SUITE 350 SEATTLE WA (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

EIN.: 831381173 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39941 | Film No.: 26857911
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)